We assessed 19,221 genes and observed a positive correlation between FIN sensitivity and the expression of several well-known NRF2 targets, including NQO1, SLC7A11, GPX2, GCLC, and FTH1, across various cancer cell lines at both the mRNA and protein levels (Figs. 2A and S2A, B). The gene discussed is NFE2L2; the disease is cancer.